top of page


U.S. FDA approves low dose Colchicine for ASCVD risk reduction
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality worldwide, affecting over 500 million individuals globally and resulting in approximately 19 million deaths annually. It is caused by the build-up of plaque that leads to hardening of the arteries. It can limit blood flow through the arteries which can result in severe conditions such as coronary heart disease, stroke, angina, or peripheral artery disease. The control of traditional c

Dr. Uttara Shankar
Sep 10, 20254 min read
Â
Â
bottom of page